Oramed Pharmaceuticals In... (ORMP)
NASDAQ: ORMP
· Real-Time Price · USD
2.19
0.04 (1.86%)
At close: May 23, 2025, 9:37 AM
1.86% (1D)
| Bid | 2.01 |
| Market Cap | 89.46M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 4.46M |
| EPS (ttm) | -0.71 |
| PE Ratio (ttm) | -3.08 |
| Forward PE | -1.68 |
| Analyst | n/a |
| Ask | 2.29 |
| Volume | 1,040 |
| Avg. Volume (20D) | 89,411 |
| Open | 2.14 |
| Previous Close | 2.15 |
| Day's Range | 2.14 - 2.19 |
| 52-Week Range | 1.82 - 3.09 |
| Beta | 1.65 |
About ORMP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ORMP
Website n/a
Earnings Surprise
Oramed Pharmaceuticals has released their quartely earnings
on May 15, 2025:
Next Earnings Release
Oramed Pharmaceuticals Inc. is scheduled to release its earnings on May 30, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+19.82%
Oramed Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
11 months ago
+14.73%
Oramed Pharmaceuticals shares are trading higher after the company announced a $20 million buyback program and finalized its joint venture with Hefei Tianhui Biotech.
